Delivery Order SPE2DR25D2007-SPE2DR26FM46A
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency Medical Supply Chain on August 19, 2025, for the supply of Albumin (Human) 25% intravenous solution in 100-milliliter units. The contract is structured as a firm fixed price delivery order with a ceiling value of $9,984.96 and an ultimate completion date of September 10, 2025. This award was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,222.80 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Albumin (Human) 5% IV Solution in 250ml units. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and no set-aside designation was used in the award. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,296 delivery order to AmerisourceBergen Drug Corp for the supply of Albumin (Human) 25% Intravenous Solution in 100ml units. This contract, awarded on December 29, 2025, with an ultimate completion date of January 21, 2026, represents a firm fixed price, non-set-aside procurement of pharmaceutical products. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,080.40 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Albumin (Human) 25% Intravenous Solution, 50mL. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ml on June 16, 2025, with a ceiling value of $2,296.00 and ultimate completion date of July 9, 2025. This competitively awarded, firm fixed price delivery order was issued without a set-aside designation and will be performed in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,300.30 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Albumin (Human) 25% Intravenous Solution in 50mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,040.20, is for the delivery of Albumin (Human) 25% IV Solution 50ML and has an ultimate completion date of April 28, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
- The Defense Logistics Agency awarded a $1,255.80 delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ml, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ML under a firm fixed-price contract valued at $2,222.80. The delivery order, which carries no set-aside designation, is scheduled for completion by December 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a single-line item procurement of pharmaceutical medical supplies essential for military...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM46ADelivery Order
This delivery order, awarded January 26, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Albumin (Human) 25% Intravenous Solution in 50 milliliter units with a ceiling value of $1,782.80 and a completion date of February 17, 2026. The award is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's parent company, Cencora, Inc.'s, significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime IDC serves as a comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen's contract portfolio with the Defense Logistics Agency demonstrates the company's established capability to fulfill federal medical procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/25/26 |